These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26186179)

  • 21. The mechanism of fibril formation of a non-inhibitory serpin ovalbumin revealed by the identification of amyloidogenic core regions.
    Tanaka N; Morimoto Y; Noguchi Y; Tada T; Waku T; Kunugi S; Morii T; Lee YF; Konno T; Takahashi N
    J Biol Chem; 2011 Feb; 286(7):5884-94. PubMed ID: 21156792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polydopamine as the Antigen Delivery Nanocarrier for Enhanced Immune Response in Tumor Immunotherapy.
    Wang N; Yang Y; Wang X; Tian X; Qin W; Wang X; Liang J; Zhang H; Leng X
    ACS Biomater Sci Eng; 2019 May; 5(5):2330-2342. PubMed ID: 33405783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells.
    Dombu C; Carpentier R; Betbeder D
    Biomaterials; 2012 Dec; 33(35):9117-26. PubMed ID: 22981076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro enhancement of mouse T helper 2 cell sensitization to ovalbumin allergen by carbon black nanoparticles.
    Lefebvre DE; Pearce B; Fine JH; Chomyshyn E; Ross N; Halappanavar S; Tayabali AF; Curran I; Bondy GS
    Toxicol Sci; 2014 Apr; 138(2):322-32. PubMed ID: 24449417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ovalbumin-coated iron oxide nanoparticles and poly(amidoamine) dendrimer-cisplatin nanocomplex for enhanced anticancer efficacy.
    Mekonnen TW; Darge HF; Tsai HC; Birhan YS; Hanurry EY; Gebrie HT; Chou HY; Lai JY; Lin SZ; Harn HJ; Chen YS
    Colloids Surf B Biointerfaces; 2022 May; 213():112391. PubMed ID: 35158218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution of vaccines comprised of hydrophobically-modified poly(γ-glutamic acid) nanoparticles and antigen proteins using fluorescence imaging.
    Toita R; Nakao K; Mahara A; Yamaoka T; Akashi M
    Bioorg Med Chem; 2013 Nov; 21(21):6608-15. PubMed ID: 24045007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice.
    Mahony D; Cavallaro AS; Stahr F; Mahony TJ; Qiao SZ; Mitter N
    Small; 2013 Sep; 9(18):3138-46. PubMed ID: 23625779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions.
    Mody KT; Mahony D; Cavallaro AS; Stahr F; Qiao SZ; Mahony TJ; Mitter N
    Int J Pharm; 2014 Apr; 465(1-2):325-32. PubMed ID: 24583208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
    Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
    Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic mice: humoral and cellular aspects.
    Sun LZ; Elsayed S; Aasen TB; Van Do T; Aardal NP; Florvaag E; Vaali K
    Scand J Immunol; 2010 May; 71(5):329-35. PubMed ID: 20500683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of components in guanidine hydrochloride to hemoglobin unfolding investigated by protein film electrochemistry.
    Mai Z; Zhao X; Dai Z; Zou X
    J Phys Chem B; 2010 May; 114(20):7090-7. PubMed ID: 20443588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity.
    Ma T; Wang L; Yang T; Ma G; Wang S
    Int J Pharm; 2014 Oct; 473(1-2):296-303. PubMed ID: 24984067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulated gastrointestinal digestion of inclusion complexes based on ovalbumin nanoparticles and conjugated linoleic acid.
    Visentini FF; Ferrado JB; Perez AA; Santiago LG
    Food Funct; 2019 May; 10(5):2630-2641. PubMed ID: 31025033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
    Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
    Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
    Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.
    Uto T; Wang X; Akagi T; Zenkyu R; Akashi M; Baba M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):600-4. PubMed ID: 19121627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.